Table 1

Clinical characteristics of consecutive patients referred to a fast-track clinic for suspected GCA

Previous year period
(21 February 2019–30 April 2019)
COVID-19 period
(21 February 2020–30 April 2020)
Number of patients referred for suspected GCA164
Female, n (%)13 (81)4 (100)
Age (years), mean±SD71±1079±6
Duration of symptoms prior to diagnosis (days), median (IQR)8 (6–28)31 (14–36)
GCA-related clinical manifestations
 Headache, n (%)13 (81)3 (75)
 Visual loss, n (%)1 (6) monolateral2 (50) bilateral
 Jaw or tongue claudication, n (%)6 (37)1 (25)
 Scalp tenderness, n (%)4 (25)0
 PMR or MSK symptoms, n (%)10 (63)3 (75)
 Constitutional symptoms, n (%)7 (44)2 (50)
  • GCA, giant cell arteritis; MSK, musculoskeletal symptoms; n, number; PMR, polymyalgia rheumatica.